OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeted Protein Degradation: Principles and Applications of the Proteasome
Yosup Kim, Eun-Kyung Kim, Yoona Chey, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1846-1846
Open Access | Times Cited: 10
Yosup Kim, Eun-Kyung Kim, Yoona Chey, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1846-1846
Open Access | Times Cited: 10
Showing 10 citing articles:
Journey of PROTAC: From Bench to Clinical Trial and Beyond
Kyli Berkley, Julian Zalejski, Nidhi Sharma, et al.
Biochemistry (2025)
Closed Access | Times Cited: 2
Kyli Berkley, Julian Zalejski, Nidhi Sharma, et al.
Biochemistry (2025)
Closed Access | Times Cited: 2
S100A4 a classical DAMP as a therapeutic target in fibrosis
Steven O’Reilly
Matrix Biology (2024)
Closed Access | Times Cited: 5
Steven O’Reilly
Matrix Biology (2024)
Closed Access | Times Cited: 5
PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
An mRNA vaccine encoding proteasome-targeted antigen enhances CD8+ T cell immunity
Ling Jin, Hongwei Chen, Mengwen Huang, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113578-113578
Closed Access
Ling Jin, Hongwei Chen, Mengwen Huang, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113578-113578
Closed Access
Proteomics analysis of porcine endometrial cell-derived extracellular vesicles involved in embryo attachment
Seonggyu Bang, Ahmad Yar Qamar, Sang-Yeop Lee, et al.
Molecular & Cellular Proteomics (2025), pp. 100942-100942
Open Access
Seonggyu Bang, Ahmad Yar Qamar, Sang-Yeop Lee, et al.
Molecular & Cellular Proteomics (2025), pp. 100942-100942
Open Access
METTL14-Mediated m6A Modification of TUG1 Represses Ferroptosis in Alzheimer's Disease via Inhibiting GDF15 Ubiquitination
Xunhu Gu, Yuanqing Song, Xu Liu, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 8
Open Access | Times Cited: 2
Xunhu Gu, Yuanqing Song, Xu Liu, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 8
Open Access | Times Cited: 2
PROteolysis‐Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives
André T. S. Vicente, Jorge A. R. Salvador
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 1
André T. S. Vicente, Jorge A. R. Salvador
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 1
Human Beta Defensin-2 mRNA and Proteasome Subunit β Type 8 mRNA Analysis, Useful in Differentiating Skin Biopsies from Atopic Dermatitis and Psoriasis Vulgaris Patients
Agnieszka Terlikowska-Brzósko, Ryszard Galus, Piotr Murawski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9192-9192
Open Access
Agnieszka Terlikowska-Brzósko, Ryszard Galus, Piotr Murawski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9192-9192
Open Access
The Autocrine Motility Factor Receptor Delays the Pathological Progression of Alzheimer's Disease via Regulating the Ubiquitination-Mediated Degradation of APP
Jingjing Zhang, Congcong Liu, Jing Liu, et al.
(2024)
Closed Access
Jingjing Zhang, Congcong Liu, Jing Liu, et al.
(2024)
Closed Access
Targeting the ubiquitin proteasome system in cancer stem cells
Hind Atta, Dina H. Kassem, Mohamed M. Kamal, et al.
Trends in Cell Biology (2024)
Closed Access
Hind Atta, Dina H. Kassem, Mohamed M. Kamal, et al.
Trends in Cell Biology (2024)
Closed Access
Current strategic trends in drug discovery: the present as prologue
David R. Janero
Expert Opinion on Drug Discovery (2023) Vol. 19, Iss. 2, pp. 147-159
Closed Access | Times Cited: 1
David R. Janero
Expert Opinion on Drug Discovery (2023) Vol. 19, Iss. 2, pp. 147-159
Closed Access | Times Cited: 1
